Microvascular disease impairs tissue perfusion and immune response
Strict glycemic control reduces risk of treatment failure and recurrence
Endocrinology partnership is standard of care
Monitoring framework
Serial ESR and CRP for treatment response
Gallium-67 or FDG-PET/CT for antibiotic cessation decision
ENT follow-up at 1 week intervals during acute phase
Long-term follow-up for at least 1 year post-treatment for recurrence surveillance
Patient Discharge Instructions
copy discharge instructions
Malignant otitis externa — what you need to know
This is a serious ear bone infection that requires long-term antibiotic treatment
Do not stop antibiotics early even if feeling better
Full course is 6 to 8 weeks — stopping early causes relapse
Take all medications exactly as prescribed
Ciprofloxacin must be taken on an empty stomach for best absorption
Do not take antacids, calcium, or iron within 2 hours of ciprofloxacin
Ear care instructions
Do not insert anything into the ear canal
No cotton swabs
No ear canal irrigation
Keep the ear dry
No swimming
Use a cotton ball with petroleum jelly for showering
Apply prescribed ear drops as directed by your ENT
Diabetic control is critical
Check blood sugar as prescribed
Target fasting glucose as directed by your doctor
Keep a glucose log to bring to follow-up appointments
Take your diabetes medications without missing doses
Insulin schedule as prescribed
Poor sugar control worsens the infection and raises relapse risk
Warning signs — return to the emergency room immediately for
New weakness or drooping of the face
Difficulty swallowing or hoarseness of voice
New shoulder weakness
Worsening ear pain despite antibiotics
Fever, chills, or rigors
Confusion or altered mental status
Severe headache
Inability to take oral antibiotics due to vomiting
Follow-up schedule
ENT appointment within 1 week of discharge
Bring culture results and antibiotic records
Infectious disease follow-up as scheduled
Blood tests (ESR, CRP) at follow-up appointments
Special imaging scans (Gallium or PET scan) will be arranged at 6 weeks
Continue follow-up for at least 1 year after finishing antibiotics
References
Guidelines and key sources
Primary clinical references
Long DA, Koyfman A, Long B — Emergency Medicine-Focused Review of Malignant Otitis Externa, American Journal of Emergency Medicine 2020
Rubin Grandis J, Branstetter BF, Yu VL — The Changing Face of Malignant (Necrotising) External Otitis, Lancet Infectious Diseases 2004
Patel S, Owen GS, Vivas EX — Otitis Externa and Malignant Otitis Externa for the Hospitalist/Internist, Medical Clinics of North America 2026
Treviño González JL, Reyes Suárez LL, Hernández de León JE — Malignant Otitis Externa: An Updated Review, American Journal of Otolaryngology 2021
Evidence and diagnostic studies
Key diagnostic and treatment studies
Stocker M, Hempel JM — Patient Cases with Malignant Otitis Externa at Ludwig Maximilians University Munich 2009 to 2020, Scientific Reports 2025 — ESR and CRP likelihood ratios
Handzel O, Halperin D — Necrotizing (Malignant) External Otitis, American Family Physician 2003 — antibiotic regimen evidence
Pulcini C et al — Antibiotic Therapy in Necrotising External Otitis: Case Series 32 Patients, European Journal of Clinical Microbiology 2012
Sadé J et al — Ciprofloxacin Treatment of Malignant External Otitis, American Journal of Medicine 1989
Phillips JS, Jones SE — Hyperbaric Oxygen as Adjuvant Treatment for MOE, Cochrane Database Systematic Reviews 2013
Stern Shavit S et al — FDG-PET/CT for Diagnosis and Follow-Up of Necrotizing External Otitis, Laryngoscope 2019
Agarwal M et al — ACR Appropriateness Criteria Inflammatory Ear Disease, Journal of the American College of Radiology 2025
Krawiec E et al — Epidemiology and Risk Factors for Extension of Necrotizing Otitis Externa, European Archives of ORL 2024
Tabashiri A et al — Clinical and Radiological Features of Patients with MOE, BMC Infectious Diseases 2025
Haleem AH et al — Refining Necrotising Otitis Externa Management and Role of Nuclear Medicine Imaging, American Journal of Otolaryngology 2025
Coding reference
Diagnostic coding
ICD-10 H60.2 malignant otitis externa
ICD-10 H60.319 acute otitis externa (simple)
ICD-10 C44.20 squamous cell carcinoma EAC
ICD-10 A41.9 sepsis unspecified organism
SNOMED CT necrotizing otitis externa disorder
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.